Two or four injections of platelet-rich plasma for osteoarthritic knee did not change synovial biomarkers but similarly improved clinical outcomes

• Published in: Scientific reports Vol. 11; no. 1; p. 23603
• Main Authors: Ngarmukos, Srihatach, Tanavalee, Chotetawan, Amarase, Chavarin, Phakham, Suphattra, Mingsiritham, Warayapa, Reantragoon, Rangsima, Leearamwat, Nitigorn, Kongkaew, Thidarat, Tharakhet, Kittipan, Honsawek, Sittisak, Dechsupa, Sinsuda, Tanavalee, Aree
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 08.12.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 692/308/409; 692/4023/1671; 692/699; Aged; Arthritis; Biomarkers; Biomarkers - metabolism; Body mass index; Clinical outcomes; Cytokines; Female; Growth factors; Humanities and Social Sciences; Humans; IL-1β; Inflammation; Injection; Injections, Intra-Articular; Interleukin 1 receptor antagonist; Interleukin 1 receptors; Interleukin 10; Interleukin 13; Interleukin 4; Interleukin 6; Knee; Male; Middle Aged; multidisciplinary; Osteoarthritis; Osteoarthritis, Knee - therapy; Patients; Platelet-derived growth factor; Platelet-derived growth factor BB; Platelet-Rich Plasma; Platelets; Science; Science (multidisciplinary); Synovial fluid; Synovial Membrane - metabolism; Transforming growth factor-b1; Treatment Outcome; Tumor necrosis factor; Vascular endothelial growth factor
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-03081-6

We compared two and four intra-articular injections of platelet-rich plasma ( PRP) in terms of changes of synovial cytokines and clinical outcomes. One hundred twenty-five patients having knee osteoarthritis (OA) underwent PRP injections at a 6-week interval. Before each PRP injection, synovial fluid aspiration was collected for investigation. Patients were divided into two or four intra-articular PRP injections (group A and B, respectively). Changes in synovial biomarkers were compared with the baseline levels of both groups, and clinical outcomes were evaluated until one year. Ninety-four patients who had completed synovial fluid collection were included for final evaluation, 51 in group A and 43 in group B. There were no differences in mean age, gender, body mass index (BMI), and radiographic OA grading. The average platelet count and white blood cell count in PRP were 430,000/µL and 200/ µL, respectively. There were no changes of synovial inflammatory cytokines (IL-1β, IL-6, IA-17A, and TNF-alpha), anti-inflammatory cytokines (IL-4, IL-10, IL-13, and IL-1RA), and growth factors (TGF-B1, VEGF, PDGF-AA, and PDGF-BB) between baseline levels and six weeks in group A, and 18 weeks in group B. Both groups had significantly improved clinical outcomes from six weeks including visual analog scale (VAS), patient-reported outcome measures [PROMs; Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index and Short Form-12 (SF-12)], with a significant delayed improvement of performance-based measures [PBMs; time up and go (TUG), 5-time sit to stand test (5 × SST), and 3-min walk test (3-min WT)]. In conclusion, two- or four-PRP intra-articular injection at a 6-week interval for knee OA demonstrated no changes of synovial cytokines and growth factors but similarly improved clinical outcomes from 6 weeks until 1 year.